-
Drug Discovery & Therapeutics2 days agoBone Marrow-on-a-Chip Model Offers New Window Into Immune Cell Development and Behavior
By reproducing elements of human bone marrow on a chip, scientists have created a new tool that will help them gain new insights into how immune...
-
Drug Discovery & Therapeutics2 days agoSTAT+: Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
-
Drug Discovery & Therapeutics2 days agoTranscenta Therapeutics and WuXi Biologics Team Up to Accelerate Commercialization of HiCB Technology
Transcenta, headquartered in China and with a pipeline of over ten therapeutic antibody candidates, is a clinical-stage biopharmaceutical company with expertise in biologics discovery, translational research,...
-
Drug Discovery & Therapeutics2 days agoDisc sets up polycythemia vera challenge but Silence maintains lead
The polycythemia vera field is heating up, with Disc Medicine and Silence Therapeutics each advancing next-generation therapies, playing catch-up to Takeda and Protagonist Therapeutics, who won...
-
Drug Discovery & Therapeutics2 days agoRewriting the rules of genetic medicine with tRNA therapeutics
Our guest today is Dr. Nerissa Kreher, Chief Medical Officer of Alltrna. Nerissa brings two decades of rare disease drug development experience. The post Rewriting the...
-
Drug Discovery & Therapeutics3 days agoGenomic diversity and antibiotic resistance in porcine F18 E. coli strains
A team of American researchers has taken one of the most detailed looks yet at emerging strains of enterotoxigenic Escherichia coli (ETEC) circulating on US pig...
-
Drug Discovery & Therapeutics3 days agoChronic Interferon Exposure Linked to Immunosuppression in Cancer
A preclinical study uncovered a novel pathway that links chronic IFN-II exposure to mitochondrial dysfunction and ultimately immunosuppression in cancer, creating foundational insights that may point...
Carbon Dots Emerge as a Powerful Weapon Against Superbugs and Biofilms
Your Zip Code May Shape Your Breast Cancer Tumor’s Genetics and Your Survival Odds
Azithromycin Resistance in Gonorrhea Shifts Genetic Ground, Challenging Molecular Surveillance
Scientists turn pig semen extract into eye drops that kill cancer in mice
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
